GlassScriptPhysician profile
Jack L Schwade
NPI 1245317742
$8,072.28
in general payments reported to CMS, 2019-2025
40 companies · $426 in 2025
The $426 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,732 · 2020: $584 · 2021: $1,166 · 2022: $1,756 · 2023: $1,456 · 2024: $953 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,835.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,834.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $998.78 | 2019-2025 | Uptravi, Opsumit |
| Novartis Pharmaceuticals Corporation | $720.01 | 2019-2025 | |
| Amgen INC. | $588.87 | 2019-2025 | Repatha |
| Sanofi-Aventis U.S. LLC | $585.74 | 2019-2023 | |
| Heartflow, INC. | $553.68 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $440.70 | 2021-2025 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $397.83 | 2019-2024 | Lifevest |
| Amarin Pharma, INC. | $396.41 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $356.07 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $347.02 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $316.85 | 2019-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $309.68 | 2019-2025 | |
| Alnylam Pharmaceuticals INC. | $269.87 | 2019-2025 | Onpattro |
| Janssen Pharmaceuticals, INC | $263.27 | 2019-2023 | Xarelto |
| Astellas Pharma US INC | $199.72 | 2019-2021 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Schwade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.